Haberer Registered Investment Advisor’s Biogen BIIB Stock Holding History

Haberer Registered Investment Advisor’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$16K	Sell	39 -10	-20%	-$3.94K	0.01%	209
2014 Q4	$17K	Hold	49	–	–	0.01%	204
2014 Q3	$16K	Buy	49 +21	+75%	+$6.92K	0.01%	232
2014 Q2	$9K	Buy	28 +18	+180%	+$5.42K	﹤0.01%	285
2014 Q1	$3K	Hold	10	–	–	﹤0.01%	343
2013 Q4	$3K	Sell	10 -1,035	-99%	-$268K	﹤0.01%	355
2013 Q3	$252K	Buy	1,045 +10	+1%	+$2.24K	0.09%	87
2013 Q2	$223K	Buy	+1,035	New	+$221K	0.06%	103

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Haberer Registered Investment Advisor's BIIB Position: Q1 2015 in Review

Haberer Registered Investment Advisor reduced its Biogen (BIIB) stake by 20% in Q1 2015, selling an estimated $3.94K and leaving 39 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #209.

Haberer Registered Investment Advisor first reported a position in BIIB in Q2 2013 and has held it in 8 quarters since. The position peaked at $252K in Q3 2013. 966 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

Haberer Registered Investment Advisor held 39 shares of Biogen worth $16K as of Q1 2015.
Haberer Registered Investment Advisor sold 10 Biogen shares in Q1 2015, an estimated $3.94K.
Biogen made up 0.01% of Haberer Registered Investment Advisor's portfolio in Q1 2015, its #209 holding.
Haberer Registered Investment Advisor first reported a position in Biogen in Q2 2013 and has held it in 8 quarters since.
Haberer Registered Investment Advisor's Biogen position peaked at $252K in Q3 2013.
966 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on Haberer Registered Investment Advisor's 13F filing for Q1 2015, filed 8 Apr 2015.